1Bihrle R, Foster R S, Sanghvi N T, et al. High intensity focused ultrasound for the treatment of benign prostatic hyperpleasia: early United States clinical experience. J Urol, 1994,151:1271-1275.
2Gelet A, Chapelon J Y, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol, 1996,29:174-183.
3Hill C A, ter Haar C R. High intensity focused ultrasound-potential for cancer treatment. Br J Radiol, 1995, 68: 1296-1303.
4Sullivan L D, McLoughlin M G, Goldenberg L G, et al. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br J Urol,1997,79: 172-176.
5Gelet A, Chapelon J Y, Bouvier R, et al. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol, 1999,161:156-162.
6Beerlage H P, Thuroff S, Debruyne F M J, et al. Transrectal high-intensity focused ultrasound using the nblathern device in the treatment of localized prostate carcinoma. Urology, 1999,54:273-277
7Kincaide L F, Sanghvi N T, Cummings O, et al.Noninvasive ultrasonic subtotal ablation of the prostate in dogs. Am J Vet Res, 1996, 57: 1225-1227.
8Madersbacher S, Schatzl G, Djavan B, et al. Long-term outcome of transrectal high- intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol,2000 ,37: 687-694.
9Chaussy C G, Thuroff S. High-intensive focused ultrasound in localized prostate cancer. J Endourol,2000, 14: 293-299
10Chaussy C G, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol, 2001,15:437-440.
